Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Virtual reality bootcamp aims to beat nurse burnout

NCT ID NCT07544498

Knowledge-focused Sponsor: Medical University of Graz Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests if a virtual reality (VR) training program can help nurses cope with work stress and prevent burnout. About 232 nurses from European hospitals will be randomly assigned to either the VR training or a waitlist group. The training uses a headset for eight sessions over ten weeks, teaching coping skills like problem-solving and emotion regulation. The goal is to see if this approach reduces stress and improves resilience and well-being.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 232 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Mar 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. working as a nurse in direct patient care within a clinical setting; 2. working at least 10h/week in their profession; 3. speaking the language in which the RCT is conducted sufficiently well; 4. able and willing to participate in all aspects of the study; 5. understanding and signing the appropriate informed consent form. Exclusion Criteria: 1. a diagnosed severe mental disorder associated with alterations in reality perception (e.g., delusions, hallucinations, derealization, depersonalization, or dementia), including in particular schizophrenia, bipolar disorder, severe major depressive disorder, or other psychotic disorders (lifetime); 2. a current major depressive episode or a current post-traumatic stress disorder (PTSD); 3. an acute or clinically significant medical condition that may interfere with the safe use of an XR headset or study participation, including but not limited to epilepsy, pronounced dizziness, balance disorders, or acute cardiovascular conditions; 4. an acute eye infection (e.g., conjunctivitis); 5. unstable medication related to a mental health condition, defined as recent changes in dosage or class of psychotropic medication; 6. initiation of psychotherapy or any structured stress-management training within the past three months.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Burnout are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Burnout, Psychological occupation-related stress disorder Occupational Stress Psychological Well-Being

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Burnout Mental health Occupational stress Resilience Work related stress

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    8 sites in 5 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Del Henares University Hospital

    Coslada, Madrid, 28822, Spain

  • Hospital José Joaquim Fernandes

    Beja, Beja District, 7801-849, Portugal

  • Infanta Leonor University Hospital

    Madrid, Madrid, 28031, Spain

  • Infanta Sofía University Hospital

    San Sebastián de los Reyes, Madrid, 28702, Spain

  • Klinika za psihijatriju Sveti Ivan

    Zagreb, 10000, Croatia

  • Medical University of Graz, Clinical Division of Psychiatry and Psychotherapeutic Medicine

    Graz, Styria, 8036, Austria

  • Summa 112

    Madrid, Madrid, 28005, Spain

  • University Medical Center of Johannes Gutenberg University Mainz

    Mainz, Rhineland-Palatinate, 55131, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.